Cargando…
Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis
Temozolomide (TMZ) resistance is a major obstacle in glioma treatment. Nuclear protein-1 (NUPR1) is a regulator of glioma progression. This study investigated the mechanism of NUPR1 in TMZ resistance in hypoxia-treated glioma cells and its mechanism in modulating autophagy. We treated TMZ-resistant...
Autores principales: | LI, TAO, FU, XIN, WANG, JIE, SHANG, WEI, WANG, XIAOTONG, ZHANG, LINYUN, LI, JUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229302/ https://www.ncbi.nlm.nih.gov/pubmed/37305393 http://dx.doi.org/10.32604/or.2023.028724 |
Ejemplares similares
-
nurP28, a New-to-Nature Zein-Derived Peptide, Enhances the Therapeutic Effect of Docetaxel in Breast Cancer Monolayers and Spheroids
por: Trinidad-Calderón, Plinio Alejandro, et al.
Publicado: (2022) -
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019) -
Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014) -
Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010) -
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
por: Wang, Zhen, et al.
Publicado: (2017)